Skip Ribbon Commands
Skip to main content

Technology Development & Commercialisation Office

For Investors

The SNEC Ophthalmic Technologies Incubator

The TD&C team oversees the operation of the SERI-SNEC ophthalmic technologies incubator. This framework is intended to facilitate the close, focused, flexible and rapid nurturing and development of a series of technologies which will later form a string of medical technology companies. Building on the continuously growing SERI IP portfolio, these start-up-oriented technology development projects give SERI a unique portfolio which has market attractiveness in a wide range of fields. Since 2014, four start-ups have emerged from R&D activities conducted at SERI, and we are working on a number of additional exciting technologies which we believe will have a substantial impact on their respective markets in coming years.

If you would like to hear more about the incubator, the technologies currently being developed within it and explore potential involvement, please send an email to for further discussion.